Drug Development

Blog Post

MDA Advocacy in These Uncertain Times

By Mark Fisher | March 19, 2020
Blog Post

NS Pharma Launches Expanded Access Program for Viltolarsen

By Jeanene Swanson | March 9, 2020
Illustration of DNA
Blog Post

FDA Accepts NS Pharma’s NDA for Viltolarsen for the Treatment of DMD Amenable to Exon 53 Skipping

By Jeanene Swanson | February 26, 2020
Blog Post

MDA’s New Chief Research Officer Sharon Hesterlee Shares Vision for the Future

By Jeanene Swanson | February 21, 2020
Blog Post

Clinical Trial Alert: Expansion Therapeutics Seeks Participants for a Phase 1 DM1 Study

By MDA Staff | February 18, 2020
Blog Post

Clinical Trial Alert: LGMD2I Participants Sought for a Phase 3 Study

By MDA Staff | February 11, 2020
Blog Post

Clinical Trial Alert: Mitsubishi Tanabe Pharma Seeks Participants for a Phase 3 ALS Study

By MDA Staff | February 5, 2020
Blog Post

Roche Genentech Announces Positive Results from Pivotal Study of Risdiplam in SMA Type 1

By Jeanene Swanson | January 31, 2020
Blog Post

MDA’s 2020 Advocacy Plan

By Mark Fisher | January 27, 2020
Blog Post

Clinical Trial Alert: Individuals with SMA Type 3 Sought for a Phase 2 Study

By MDA Staff | January 27, 2020